ORLANDO, Fla., Aug. 30, 2016 (GLOBE NEWSWIRE) -- Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, installed a Renaissance® Guidance System at Grand Strand Medical Center in Myrtle Beach, SC on July 6, 2016 and has since completed an initial case series. Grand Strand is the second in the state of South Carolina and the ninth HCA-affiliated facility to purchase a Renaissance system. See how Renaissance works.
"One of our main goals is to help improve outcomes for our patients," said Mark Sims, Chief Executive Officer for Grand Strand Medical Center. "Adding the Renaissance technology to our spine surgery program will elevate the level of quality care available to our community."
Grand Strand Medical Center is a 301-bed acute care hospital serving residents of Horry and surrounding counties. The hospital offers the only cardiac surgery program, neurosurgery program and pediatric intensive care unit (PICU) in Horry and Georgetown counties and is a designated Level II Trauma Center by DHEC and the American College of Surgeons.
"Now, thanks to Grand Strand Medical Center, spine surgeons and their patients in the Myrtle Beach area have access to our technology" said Mazor Robotics Inc. CEO Christopher Prentice. "We believe in healing through innovation and we look forward to Grand Strand Medical Center redefining the standard of quality care."
About Mazor
Mazor Robotics (TASE:MZOR) (NASDAQGM:MZOR) believes in healing through innovation by developing and introducing revolutionary technologies and products aimed at redefining the gold standard of quality care. Mazor Robotics Guidance Systems enable surgeons to conduct spine and brain procedures in a precise manner. For more information, please visit www.MazorRobotics.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Any statements in this release about future expectations, plans or prospects for the Company, including without limitation, statements regarding the benefits of the Renaissance technology, and other statements containing the words believes, anticipates, plans, expects, will and similar expressions are forward-looking statements. These statements are only predictions based on Mazor's current expectations and projections about future events. There are important factors that could cause Mazor's actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. Those factors include, but are not limited to, the impact of general economic conditions, competitive products, product demand and market acceptance risks, reliance on key strategic alliances, fluctuations in operating results, and other factors indicated in Mazor's filings with the Securities and Exchange Commission (SEC) including those discussed under the heading "Risk Factors" in Mazor's annual report on Form 20-F filed with the SEC on May 2, 2016 and in subsequent filings with the SEC. For more details, refer to Mazor's SEC filings. Mazor undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in our expectations, except as may be required by law.
CONTACT:Stephani Shipman
Marketing Communications Manager
Mazor Robotics
s.shipman@mazorrobotics-us.com
(407) 591-3461